Global Immuno-oncology Clinical Trials Supply, Demand and Key Producers, 2023-2029

Description

The global Immuno-oncology Clinical Trials market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The growth can be attributed to recent developments in immuno-oncology, changes in lifestyle brought on by urbanization predisposing populations to the rise of cancer, and the growing acceptability of targeted therapy.

This report studies the global Immuno-oncology Clinical Trials demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Immuno-oncology Clinical Trials, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Immuno-oncology Clinical Trials that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Immuno-oncology Clinical Trials total market, 2018-2029, (USD Million)
Global Immuno-oncology Clinical Trials total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Immuno-oncology Clinical Trials total market, key domestic companies and share, (USD Million)
Global Immuno-oncology Clinical Trials revenue by player and market share 2018-2023, (USD Million)
Global Immuno-oncology Clinical Trials total market by Type, CAGR, 2018-2029, (USD Million)
Global Immuno-oncology Clinical Trials total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Immuno-oncology Clinical Trials market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medpace, Novartis, Exscientia, Syneous Health, AstraZeneca, ICON plc, IQVIA Holdings, BioNtech and Covance, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Immuno-oncology Clinical Trials market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Immuno-oncology Clinical Trials Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Immuno-oncology Clinical Trials Market, Segmentation by Type
    Phase I
    Phase II
    Phase III
    Phase IV

Global Immuno-oncology Clinical Trials Market, Segmentation by Application
    Solid Tumors
    Hematological Cancer

Companies Profiled:
    Medpace
    Novartis
    Exscientia
    Syneous Health
    AstraZeneca
    ICON plc
    IQVIA Holdings
    BioNtech
    Covance, Inc.
    IO BIOTECH

Key Questions Answered
1. How big is the global Immuno-oncology Clinical Trials market?
2. What is the demand of the global Immuno-oncology Clinical Trials market?
3. What is the year over year growth of the global Immuno-oncology Clinical Trials market?
4. What is the total value of the global Immuno-oncology Clinical Trials market?
5. Who are the major players in the global Immuno-oncology Clinical Trials market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Immuno-oncology Clinical Trials Introduction
    1.2 World Immuno-oncology Clinical Trials Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Immuno-oncology Clinical Trials Total Market by Region (by Headquarter Location)
        1.3.1 World Immuno-oncology Clinical Trials Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Immuno-oncology Clinical Trials Market Size (2018-2029)
        1.3.3 China Immuno-oncology Clinical Trials Market Size (2018-2029)
        1.3.4 Europe Immuno-oncology Clinical Trials Market Size (2018-2029)
        1.3.5 Japan Immuno-oncology Clinical Trials Market Size (2018-2029)
        1.3.6 South Korea Immuno-oncology Clinical Trials Market Size (2018-2029)
        1.3.7 ASEAN Immuno-oncology Clinical Trials Market Size (2018-2029)
        1.3.8 India Immuno-oncology Clinical Trials Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Immuno-oncology Clinical Trials Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Immuno-oncology Clinical Trials Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Immuno-oncology Clinical Trials Consumption Value (2018-2029)
    2.2 World Immuno-oncology Clinical Trials Consumption Value by Region
        2.2.1 World Immuno-oncology Clinical Trials Consumption Value by Region (2018-2023)
        2.2.2 World Immuno-oncology Clinical Trials Consumption Value Forecast by Region (2024-2029)
    2.3 United States Immuno-oncology Clinical Trials Consumption Value (2018-2029)
    2.4 China Immuno-oncology Clinical Trials Consumption Value (2018-2029)
    2.5 Europe Immuno-oncology Clinical Trials Consumption Value (2018-2029)
    2.6 Japan Immuno-oncology Clinical Trials Consumption Value (2018-2029)
    2.7 South Korea Immuno-oncology Clinical Trials Consumption Value (2018-2029)
    2.8 ASEAN Immuno-oncology Clinical Trials Consumption Value (2018-2029)
    2.9 India Immuno-oncology Clinical Trials Consumption Value (2018-2029)

3 World Immuno-oncology Clinical Trials Companies Competitive Analysis
    3.1 World Immuno-oncology Clinical Trials Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Immuno-oncology Clinical Trials Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Immuno-oncology Clinical Trials in 2022
        3.2.3 Global Concentration Ratios (CR8) for Immuno-oncology Clinical Trials in 2022
    3.3 Immuno-oncology Clinical Trials Company Evaluation Quadrant
    3.4 Immuno-oncology Clinical Trials Market: Overall Company Footprint Analysis
        3.4.1 Immuno-oncology Clinical Trials Market: Region Footprint
        3.4.2 Immuno-oncology Clinical Trials Market: Company Product Type Footprint
        3.4.3 Immuno-oncology Clinical Trials Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Immuno-oncology Clinical Trials Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Immuno-oncology Clinical Trials Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Immuno-oncology Clinical Trials Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Immuno-oncology Clinical Trials Consumption Value Comparison
        4.2.1 United States VS China: Immuno-oncology Clinical Trials Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Immuno-oncology Clinical Trials Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Immuno-oncology Clinical Trials Companies and Market Share, 2018-2023
        4.3.1 United States Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Immuno-oncology Clinical Trials Revenue, (2018-2023)
    4.4 China Based Companies Immuno-oncology Clinical Trials Revenue and Market Share, 2018-2023
        4.4.1 China Based Immuno-oncology Clinical Trials Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Immuno-oncology Clinical Trials Revenue, (2018-2023)
    4.5 Rest of World Based Immuno-oncology Clinical Trials Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Immuno-oncology Clinical Trials Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Immuno-oncology Clinical Trials Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Phase I
        5.2.2 Phase II
        5.2.3 Phase III
        5.2.4 Phase IV
    5.3 Market Segment by Type
        5.3.1 World Immuno-oncology Clinical Trials Market Size by Type (2018-2023)
        5.3.2 World Immuno-oncology Clinical Trials Market Size by Type (2024-2029)
        5.3.3 World Immuno-oncology Clinical Trials Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Immuno-oncology Clinical Trials Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Solid Tumors
        6.2.2 Hematological Cancer
    6.3 Market Segment by Application
        6.3.1 World Immuno-oncology Clinical Trials Market Size by Application (2018-2023)
        6.3.2 World Immuno-oncology Clinical Trials Market Size by Application (2024-2029)
        6.3.3 World Immuno-oncology Clinical Trials Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Medpace
        7.1.1 Medpace Details
        7.1.2 Medpace Major Business
        7.1.3 Medpace Immuno-oncology Clinical Trials Product and Services
        7.1.4 Medpace Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Medpace Recent Developments/Updates
        7.1.6 Medpace Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Immuno-oncology Clinical Trials Product and Services
        7.2.4 Novartis Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 Exscientia
        7.3.1 Exscientia Details
        7.3.2 Exscientia Major Business
        7.3.3 Exscientia Immuno-oncology Clinical Trials Product and Services
        7.3.4 Exscientia Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Exscientia Recent Developments/Updates
        7.3.6 Exscientia Competitive Strengths & Weaknesses
    7.4 Syneous Health
        7.4.1 Syneous Health Details
        7.4.2 Syneous Health Major Business
        7.4.3 Syneous Health Immuno-oncology Clinical Trials Product and Services
        7.4.4 Syneous Health Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Syneous Health Recent Developments/Updates
        7.4.6 Syneous Health Competitive Strengths & Weaknesses
    7.5 AstraZeneca
        7.5.1 AstraZeneca Details
        7.5.2 AstraZeneca Major Business
        7.5.3 AstraZeneca Immuno-oncology Clinical Trials Product and Services
        7.5.4 AstraZeneca Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 AstraZeneca Recent Developments/Updates
        7.5.6 AstraZeneca Competitive Strengths & Weaknesses
    7.6 ICON plc
        7.6.1 ICON plc Details
        7.6.2 ICON plc Major Business
        7.6.3 ICON plc Immuno-oncology Clinical Trials Product and Services
        7.6.4 ICON plc Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 ICON plc Recent Developments/Updates
        7.6.6 ICON plc Competitive Strengths & Weaknesses
    7.7 IQVIA Holdings
        7.7.1 IQVIA Holdings Details
        7.7.2 IQVIA Holdings Major Business
        7.7.3 IQVIA Holdings Immuno-oncology Clinical Trials Product and Services
        7.7.4 IQVIA Holdings Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 IQVIA Holdings Recent Developments/Updates
        7.7.6 IQVIA Holdings Competitive Strengths & Weaknesses
    7.8 BioNtech
        7.8.1 BioNtech Details
        7.8.2 BioNtech Major Business
        7.8.3 BioNtech Immuno-oncology Clinical Trials Product and Services
        7.8.4 BioNtech Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 BioNtech Recent Developments/Updates
        7.8.6 BioNtech Competitive Strengths & Weaknesses
    7.9 Covance, Inc.
        7.9.1 Covance, Inc. Details
        7.9.2 Covance, Inc. Major Business
        7.9.3 Covance, Inc. Immuno-oncology Clinical Trials Product and Services
        7.9.4 Covance, Inc. Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Covance, Inc. Recent Developments/Updates
        7.9.6 Covance, Inc. Competitive Strengths & Weaknesses
    7.10 IO BIOTECH
        7.10.1 IO BIOTECH Details
        7.10.2 IO BIOTECH Major Business
        7.10.3 IO BIOTECH Immuno-oncology Clinical Trials Product and Services
        7.10.4 IO BIOTECH Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 IO BIOTECH Recent Developments/Updates
        7.10.6 IO BIOTECH Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Immuno-oncology Clinical Trials Industry Chain
    8.2 Immuno-oncology Clinical Trials Upstream Analysis
    8.3 Immuno-oncology Clinical Trials Midstream Analysis
    8.4 Immuno-oncology Clinical Trials Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Immuno-oncology Clinical Trials Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Immuno-oncology Clinical Trials Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Immuno-oncology Clinical Trials Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Immuno-oncology Clinical Trials Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Immuno-oncology Clinical Trials Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Immuno-oncology Clinical Trials Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Immuno-oncology Clinical Trials Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Immuno-oncology Clinical Trials Players in 2022
    Table 12. World Immuno-oncology Clinical Trials Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Immuno-oncology Clinical Trials Company Evaluation Quadrant
    Table 14. Head Office of Key Immuno-oncology Clinical Trials Player
    Table 15. Immuno-oncology Clinical Trials Market: Company Product Type Footprint
    Table 16. Immuno-oncology Clinical Trials Market: Company Product Application Footprint
    Table 17. Immuno-oncology Clinical Trials Mergers & Acquisitions Activity
    Table 18. United States VS China Immuno-oncology Clinical Trials Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Immuno-oncology Clinical Trials Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Immuno-oncology Clinical Trials Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Immuno-oncology Clinical Trials Revenue Market Share (2018-2023)
    Table 23. China Based Immuno-oncology Clinical Trials Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Immuno-oncology Clinical Trials Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Immuno-oncology Clinical Trials Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Immuno-oncology Clinical Trials Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Immuno-oncology Clinical Trials Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Immuno-oncology Clinical Trials Revenue Market Share (2018-2023)
    Table 29. World Immuno-oncology Clinical Trials Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Immuno-oncology Clinical Trials Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Immuno-oncology Clinical Trials Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Immuno-oncology Clinical Trials Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Immuno-oncology Clinical Trials Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Immuno-oncology Clinical Trials Market Size by Application (2024-2029) & (USD Million)
    Table 35. Medpace Basic Information, Area Served and Competitors
    Table 36. Medpace Major Business
    Table 37. Medpace Immuno-oncology Clinical Trials Product and Services
    Table 38. Medpace Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Medpace Recent Developments/Updates
    Table 40. Medpace Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis Immuno-oncology Clinical Trials Product and Services
    Table 44. Novartis Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. Exscientia Basic Information, Area Served and Competitors
    Table 48. Exscientia Major Business
    Table 49. Exscientia Immuno-oncology Clinical Trials Product and Services
    Table 50. Exscientia Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Exscientia Recent Developments/Updates
    Table 52. Exscientia Competitive Strengths & Weaknesses
    Table 53. Syneous Health Basic Information, Area Served and Competitors
    Table 54. Syneous Health Major Business
    Table 55. Syneous Health Immuno-oncology Clinical Trials Product and Services
    Table 56. Syneous Health Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Syneous Health Recent Developments/Updates
    Table 58. Syneous Health Competitive Strengths & Weaknesses
    Table 59. AstraZeneca Basic Information, Area Served and Competitors
    Table 60. AstraZeneca Major Business
    Table 61. AstraZeneca Immuno-oncology Clinical Trials Product and Services
    Table 62. AstraZeneca Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. AstraZeneca Recent Developments/Updates
    Table 64. AstraZeneca Competitive Strengths & Weaknesses
    Table 65. ICON plc Basic Information, Area Served and Competitors
    Table 66. ICON plc Major Business
    Table 67. ICON plc Immuno-oncology Clinical Trials Product and Services
    Table 68. ICON plc Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. ICON plc Recent Developments/Updates
    Table 70. ICON plc Competitive Strengths & Weaknesses
    Table 71. IQVIA Holdings Basic Information, Area Served and Competitors
    Table 72. IQVIA Holdings Major Business
    Table 73. IQVIA Holdings Immuno-oncology Clinical Trials Product and Services
    Table 74. IQVIA Holdings Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. IQVIA Holdings Recent Developments/Updates
    Table 76. IQVIA Holdings Competitive Strengths & Weaknesses
    Table 77. BioNtech Basic Information, Area Served and Competitors
    Table 78. BioNtech Major Business
    Table 79. BioNtech Immuno-oncology Clinical Trials Product and Services
    Table 80. BioNtech Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. BioNtech Recent Developments/Updates
    Table 82. BioNtech Competitive Strengths & Weaknesses
    Table 83. Covance, Inc. Basic Information, Area Served and Competitors
    Table 84. Covance, Inc. Major Business
    Table 85. Covance, Inc. Immuno-oncology Clinical Trials Product and Services
    Table 86. Covance, Inc. Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Covance, Inc. Recent Developments/Updates
    Table 88. IO BIOTECH Basic Information, Area Served and Competitors
    Table 89. IO BIOTECH Major Business
    Table 90. IO BIOTECH Immuno-oncology Clinical Trials Product and Services
    Table 91. IO BIOTECH Immuno-oncology Clinical Trials Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 92. Global Key Players of Immuno-oncology Clinical Trials Upstream (Raw Materials)
    Table 93. Immuno-oncology Clinical Trials Typical Customers
List of Figure
    Figure 1. Immuno-oncology Clinical Trials Picture
    Figure 2. World Immuno-oncology Clinical Trials Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Immuno-oncology Clinical Trials Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Immuno-oncology Clinical Trials Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Immuno-oncology Clinical Trials Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Immuno-oncology Clinical Trials Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Immuno-oncology Clinical Trials Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Immuno-oncology Clinical Trials Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Immuno-oncology Clinical Trials Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Immuno-oncology Clinical Trials Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Immuno-oncology Clinical Trials Revenue (2018-2029) & (USD Million)
    Figure 13. Immuno-oncology Clinical Trials Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Immuno-oncology Clinical Trials Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Immuno-oncology Clinical Trials Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Immuno-oncology Clinical Trials by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Immuno-oncology Clinical Trials Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Immuno-oncology Clinical Trials Markets in 2022
    Figure 27. United States VS China: Immuno-oncology Clinical Trials Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Immuno-oncology Clinical Trials Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Immuno-oncology Clinical Trials Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Immuno-oncology Clinical Trials Market Size Market Share by Type in 2022
    Figure 31. Phase I
    Figure 32. Phase II
    Figure 33. Phase III
    Figure 34. Phase IV
    Figure 35. World Immuno-oncology Clinical Trials Market Size Market Share by Type (2018-2029)
    Figure 36. World Immuno-oncology Clinical Trials Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Immuno-oncology Clinical Trials Market Size Market Share by Application in 2022
    Figure 38. Solid Tumors
    Figure 39. Hematological Cancer
    Figure 40. Immuno-oncology Clinical Trials Industrial Chain
    Figure 41. Methodology
    Figure 42. Research Process and Data Source